Preterm birth remains the leading cause of death in children under five worldwide, and infection-associated cases are among the hardest to prevent. When bacteria or bacterial products such as lipopolysaccharide (LPS) invade the amniotic cavity, they trigger intra-amniotic inflammation, a process that can culminate in spontaneous preterm birth and fetal inflammatory response syndrome, or FIRS — a systemic inflammatory condition in the fetus associated with neonatal mortality, organ injury, and lifelong neurodevelopmental consequences. While the downstream mechanics of labor — oxytocin signaling, prostaglandin release, cervical remodeling — are well mapped, the specific innate immune sensors that first break maternal-fetal tolerance and set the inflammatory parturition cascade in motion have remained elusive. The new work points squarely at Mincle as one such gatekeeper.

To test Mincle’s role in vivo, the team developed a technically demanding model. Using high-resolution ultrasound guidance, they microinjected LPS directly into the amniotic cavities of pregnant mice at 16.5 days post-coitum — a gestational stage roughly analogous to the late third trimester in humans — in both wild-type animals and mice engineered to lack Mincle specifically in myeloid cells, the macrophages and neutrophils that form the front line of innate immunity. This precise delivery method ensured that the inflammatory insult was localized to the intra-amniotic compartment, mimicking the ascending infections seen clinically, rather than producing systemic maternal sepsis.

The results were striking. In wild-type dams, intra-amniotic LPS exposure triggered preterm birth in approximately half of the animals, accompanied by profound neonatal mortality. In the Mincle-deficient mice, premature parturition was completely abolished: the animals carried their pregnancies to term, and neonatal survival and postnatal growth trajectories were fully restored. Longitudinal assessments of gestational length and pup outcomes showed that removing this one receptor did not merely delay or soften the inflammatory response — it erased the pathological phenotype altogether.

The protective effect extended deep into fetal physiology. Fetal Doppler ultrasonography revealed that wild-type fetuses exposed to intra-amniotic LPS developed hyperdynamic circulation — an abnormally accelerated blood flow pattern that reflects systemic inflammatory stress and is a recognized warning sign of fetal decompensation. In Mincle knockout pregnancies, this circulatory storm never materialized, and the fetuses were spared the systemic organ inflammation that normally follows. Postnatal morphometric measurements confirmed that pups from Mincle-deficient dams grew normally, without the growth restriction typical of inflammatory preterm births.

Perhaps the most mechanistically revealing finding concerns the anatomy of the immune response. Using flow cytometric immunophenotyping, the researchers found that Mincle was uniquely required for the recruitment and functional antibacterial activation of macrophages and neutrophils — but only within the decidual compartment, the specialized maternal tissue at the maternal-fetal interface. Bulk leukocyte infiltration into the uterus as a whole was unaffected by Mincle loss. In other words, Mincle acts as a spatially restricted conductor, dictating precisely where and how inflammatory cells accumulate at the critical boundary between mother and fetus. When the receptor is absent, this localized cellular invasion simply does not occur.

High-throughput transcriptomics and immunoblotting then traced the molecular consequences downstream. In wild-type animals, decidual Mincle signaling was an essential prerequisite for the transcriptional priming of Nlrp3 — the gene encoding the sensor component of the NLRP3 inflammasome, a multiprotein complex that, once assembled, cleaves procaspase-1 into active Caspase-1, which in turn matures the potent pro-inflammatory cytokine interleukin-1β. In the Mincle-deficient mice, this entire axis collapsed: Nlrp3 priming was suppressed, Caspase-1 cleavage was prevented, and IL-1β maturation was blunted. The NLRP3 inflammasome has previously been implicated in sterile intra-amniotic inflammation and preterm labor in independent work, but this study establishes Mincle-dependent decidual inflammation as a required upstream licensing step for its intrauterine activation.

The team also examined the contractile machinery of the uterus itself. Expression of two essential myometrial contractility genes — Gja1, which encodes connexin 43, the gap junction protein that electrically couples uterine smooth muscle cells for synchronized contractions, and Oxtr, the oxytocin receptor gene — was significantly downregulated in Mincle-deficient dams following LPS exposure. This transcriptional finding helps explain, at a mechanistic level, why the knockout animals never entered premature labor: without inflammatory IL-1β signaling and without the upregulation of the molecular apparatus of coordinated uterine contraction, the mechanical onset of parturition was never triggered ahead of schedule.

Taken together, the data sketch a coherent model. Mincle, an ITAM-coupled activating receptor first characterized for sensing damaged cells and mycobacterial ligands, sits at the top of a spatially confined signaling hierarchy at the maternal-fetal interface. Upon encountering inflammatory danger in the amniotic cavity, it governs the localized recruitment and activation of decidual macrophages and neutrophils; these cells then license NLRP3 inflammasome assembly, driving IL-1β maturation that simultaneously primes the myometrium for contraction — producing preterm labor — and generates the systemic fetal toxicity characteristic of FIRS. Disrupting the first node in this hierarchy cascades into protection at every downstream level, from cellular infiltration to cytokine maturation to fetal hemodynamics.

The therapeutic implications are considerable. Because Mincle is a cell-surface C-type lectin receptor with well-characterized signaling machinery, it represents an unusually druggable target. Small-molecule inhibitors, blocking antibodies, or ligand-competitive strategies aimed at the Mincle signaling axis could, in principle, simultaneously halt infection-associated preterm birth and protect the fetus from inflammatory injury — a dual benefit that current interventions such as progesterone, cerclage, and tocolytics cannot offer. The authors suggest that targeting Mincle could become a precision-medicine strategy to safeguard lifelong perinatal health, though they and outside observers caution that mouse models of LPS-induced inflammation do not capture the full complexity of human intra-amniotic infection, and translating myeloid-specific receptor blockade into pregnancy-safe therapeutics will require extensive validation. The study was supported by the Shenzhen Science and Technology Innovation Commission and the Health System Research Project of Futian District, Shenzhen.